S1414 Immunomodulator Therapy is Associated With Higher Incidence of Primary Sclerosing Cholangitis and Colorectal Cancer Compared to Biologic Therapy: A Propensity-Matched Cohort Study
Nawaz A, Shah A, Chaar A, Singh K, Aswath G, Khan H, John S. S1414 Immunomodulator Therapy is Associated With Higher Incidence of Primary Sclerosing Cholangitis and Colorectal Cancer Compared to Biologic Therapy: A Propensity-Matched Cohort Study. The American Journal Of Gastroenterology 2024, 119: s1012-s1012. DOI: 10.14309/01.ajg.0001035024.11002.ae.Peer-Reviewed Original ResearchS1413 Impact of Race on Clinical Outcomes in IBD Patients on Anti-TNF Monotherapy and Anti-TNF Combination Therapy With Immunomodulators: A Propensity-Matched Cohort Study
Nawaz A, Almasaid S, Shah A, Hussain A, Chaar A, Patel S, Khalid F, Hayat U, Singh K, Aswath G, Khan H. S1413 Impact of Race on Clinical Outcomes in IBD Patients on Anti-TNF Monotherapy and Anti-TNF Combination Therapy With Immunomodulators: A Propensity-Matched Cohort Study. The American Journal Of Gastroenterology 2024, 119: s1011-s1012. DOI: 10.14309/01.ajg.0001035020.13797.dd.Peer-Reviewed Original Research